CIK 0001729427 · Non-accelerated filer<br>Smaller reporting company
CNS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CNSP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 822318545
- Phone
- 1-800-946-9185
- Business address
- 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-14 | Priebe Waldemar 10% owner | Sale 10b5-1 | −5,000 | $1.35 | $7K | 216,807 |
| 2023-03-13 | Priebe Waldemar 10% owner | Sale 10b5-1 | −5,000 | $1.30 | $7K | 221,807 |
| 2023-03-10 | Priebe Waldemar 10% owner | Sale 10b5-1 | −5,000 | $1.29 | $6K | 226,807 |
| 2022-12-30 | Charles Faith L. Director | Grant or award · Option to purchase common stock | +3,500 | 3,500 | ||
| 2022-12-09 | Priebe Waldemar 10% owner | Sale 10b5-1 | −2,798 | $2.43 | $7K | 231,807 |
| 2022-12-08 | Priebe Waldemar 10% owner | Sale 10b5-1 | −5,500 | $2.40 | $13K | 234,605 |
| 2022-12-07 | Priebe Waldemar 10% owner | Sale 10b5-1 | −5,500 | $2.46 | $14K | 240,105 |
| 2022-12-06 | Priebe Waldemar 10% owner | Sale 10b5-1 | −5,500 | $2.47 | $14K | 245,605 |
| 2022-04-28 | Downs Christopher Chief Financial Officer | Grant or award · Restricted Stock Units | +250,000 | 681,000 | ||
| 2022-04-28 | Climaco John M Chief Executive Officer | Grant or award · Restricted Stock Units | +600,000 | 1,349,500 | ||
| 2022-03-11 | Downs Christopher Chief Financial Officer | Grant or award | +33,000 | $0.31 | $10K | 184,500 |
| 2022-03-08 | Evans Carl Anthony Director | Grant or award | +3,750 | $0.27 | $1K | 3,750 |
| 2022-03-07 | Keyes Jeffry R. Director | Grant or award | +11,100 | $0.30 | $3K | 11,100 |
| 2022-03-07 | Climaco John M Chief Executive Officer | Grant or award | +35,000 | $0.28 | $10K | 940,298 |
| 2021-12-06 | Downs Christopher Chief Financial Officer | Purchase | +5,000 | $0.94 | $5K | 151,500 |
| 2021-11-19 | Downs Christopher Chief Financial Officer | Purchase | +4,500 | $1.15 | $5K | 146,500 |
| 2021-11-16 | Climaco John M Chief Executive Officer | Grant or award | +5,000 | $1.28 | $6K | 905,298 |
| 2021-07-15 | Keyes Jeffry R. Director | Grant or award · Option to purchase common stock | +32,000 | 178,559 | ||
| 2021-07-15 | Gumulka Jerzy Director | Grant or award · Option to purchase common stock | +32,000 | 178,559 | ||
| 2021-07-15 | Andraczke Andrzej Director | Grant or award · Option to purchase common stock | +32,000 | 178,559 |
Page 5 of 6 · 110 trades